« Previous
Next »
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 2, Issue 1
, Pages 36-42
, January 2006
Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia
References
- Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology . Neurology . 2001;56:1143–1153
- Voxel-based morphometry to discriminate early Alzheimer’s disease from controls . Neurosci Lett . 2005;382:269–274
-
Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing
(Diagnostic value and neuropsychological correlates)
.
J Neurol Neurosurg Psychiatr
. 1992;55:967–972
- MRI of the hippocampus in Alzheimer’s disease (Sensitivity, specificity, and analysis of the incorrectly classified subjects) . Neurobiol Aging . 1998;19:23–31
- Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia (an MRI study) . Neurology . 1996;46:678–681
- Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease . Neurology . 1999;52:91–100
- Relationship between clinical and radiological diagnostic criteria for Alzheimer’s disease and the extent of neuropathology as reflected by ‘stages’ (a prospective study) . Dement Geriatr Cogn Disord . 1999;10:109–114
- . Hippocampal volume as an index of Alzheimer neuropathology (findings from the Nun Study) . Neurology . 2002;58:1476–1482
- Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia . Neurology . 2002;58:750–757
- . Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD . Neurology . 2005;64:1032–1039
- . Visualization and quantification of rates of atrophy in Alzheimer’s disease . Lancet . 1996;348:94–97
- . Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer’s disease . Lancet . 1999;353:2125
- Changes in premorbid brain volume predict Alzheimer’s disease pathology . Neurology . 2003;61:487–492
- Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment . Neurology . 1999;52:1397–1403
- . Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment . J Neurol Neurosurg Psychiatry . 2002;72:491–497
- Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD . Neurology . 2004;62:591–600
- Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI . Neurology . 2005;65:1227–1231
- MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD . Neurobiol Aging . 2004;25:1197–1203
- Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia . Neurology . 2004;63:220–227
- . A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET . J Nucl Med . 1995;36:1238–1248
- . Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease . Ann Neurol . 1997;42:85–94
- . PET studies in dementia . Ann Nucl Med . 2003;17:79–89
- . Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies . Br J Psychiatry . 1999;174:45–50
- Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series . J Am Geriatr Soc . 1999;47:564–569
- FDG PET imaging in patients with pathologically verified dementia . J Nucl Med . 2000;41:1920–1928
- Positron emission tomography in evaluation of dementia (Regional brain metabolism and long-term outcome) . JAMA . 2001;286:2120–2127
- SPECT perfusion imaging in the diagnosis of Alzheimer’s disease (A clinical-pathologic study) . Neurology . 2001;56:950–956
-
.
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
.
Neurolgy
. 1996;47:462–466
- Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease (A comparative study using positron emission tomography) . Neurosci Lett . 1997;235:49–52
- . Alzheimer’s disease versus dementia with Lewy bodies (cerebral metabolic distinction with autopsy confirmation) . Ann Neurol . 2001;50:358–365
- Cerebral glucose metabolism in patients with frontotemporal dementia . J Nucl Med . 1998;39:1875–1878
- Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer’s disease and frontotemporal dementia at initial diagnosis . Eur Neurol . 2001;45:19–27
- Preclinical evidence of Alzheimer’s disease in persons homozygous for the e4 allele for apolipoprotein E . N Engl J Med . 1996;334:752–758
- Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia . Proc Natl Acad Sci U S A . 2004;101:284–289
- Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer’s disease . Neurosci Lett . 1995;186:17–20
- Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment . Neuroreport . 2001;12:851–855
- . Mild cognitive impairment (Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?) . Neurology . 2003;60:1374–1377
- Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET) . Proc Natl Acad Sci U S A . 2001;98:10966–10971
- Medial temporal lobe function and structure in mild cognitive impairment . Ann Neurol . 2004;56:27–35
- . Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease . Ann Neurol . 1999;45:466–472
- Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease . Neurology . 1999;53:1391–1396
- Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease . Am J Geriatr Psychiatry . 2002;10:24–35
- Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B . Ann Neurol . 2004;55:306–319
- In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET . Am J Geriatr Psychiatry . 2004;12:584–595
- . Alzheimer neuropathologic alterations in aged cognitively normal subjects . J Neuropathol Exp Neurol . 1999;58:376–388
-
.
Ways toward an early diagnosis in Alzheimer’s disease
(The Alzheimer’s Disease Neuroimaging Initiative)
.
Alzheimer’s and Dementia
. 2005;1:55–66
PII: S1552-5260(05)00501-7
doi: 10.1016/j.jalz.2005.11.002
© 2006 The Alzheimer’s Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 2, Issue 1
, Pages 36-42
, January 2006
